SCYNEXIS, Inc. Derivative Liability, Noncurrent
SCYNEXIS, Inc. (SCYX) had Derivative Liability, Noncurrent of $0 as of 2014-12-31, per its 8-K filed 2015-10-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DerivativeLiabilitiesNoncurrent · last filed 2016-03-07
- 2014-12-31: Derivative Liability, Noncurrent $0.00.
- 2014-09-30: Derivative Liability, Noncurrent $0.00.
- 2014-06-30: Derivative Liability, Noncurrent $0.00.
- 2014-05-07: Derivative Liability, Noncurrent $2.70M.
| Period end | Derivative Liability, Noncurrent | Derivative Liability, Noncurrent as first filed |
|---|---|---|
| 2014-12-31 | $0.00 8-K · filed 2015-10-30 | |
| 2014-09-30 | $0.00 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $0.00 10-Q · filed 2014-08-13 | |
| 2014-05-07 | $2.70M 10-Q · filed 2014-11-13 | |
| 2014-05-02 | $2.70M 10-K · filed 2016-03-07 | |
| 2014-03-31 | $10.00M 10-Q · filed 2015-11-13 | |
| 2013-12-31 | $12.20M 10-Q · filed 2015-11-13 | $12.24M 10-Q/A · filed 2014-07-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |